Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schoemaker

Showing results (311-320 of 360) with videos related to

Pageof 36
Sort By:
Nature Genetics|March 28, 2017
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumorsBeatrice S Melin, Jill S Barnholtz-Sloan, Margaret R Wrensch, et al.
Journal of the National Cancer Institute|June 19, 2018
Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 CohortsMarjorie L McCullough, Emilie S Zoltick, Stephanie J Weinstein, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Human Molecular Genetics|December 21, 2013
DNA mismatch repair gene MSH6 implicated in determining age at natural menopauseJohn R B Perry, Yi-Hsiang Hsu, Daniel I Chasman, et al.
Scientific Reports|April 14, 2022
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 womenXiaoliang Wang, Pooja Middha Kapoor, Paul L Auer, et al.
Breast Cancer Research : BCR|February 18, 2016
Genetic predisposition to ductal carcinoma in situ of the breastChristos Petridis, Mark N Brook, Vandna Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Scientific Reports|October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosisMaria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Pageof 36

Showing results (311-320 of 360) with videos related to

Sort By:
Pageof 36
Nature Genetics|March 28, 2017
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumorsBeatrice S Melin, Jill S Barnholtz-Sloan, Margaret R Wrensch, et al.
Journal of the National Cancer Institute|June 19, 2018
Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 CohortsMarjorie L McCullough, Emilie S Zoltick, Stephanie J Weinstein, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Human Molecular Genetics|December 21, 2013
DNA mismatch repair gene MSH6 implicated in determining age at natural menopauseJohn R B Perry, Yi-Hsiang Hsu, Daniel I Chasman, et al.
Scientific Reports|April 14, 2022
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 womenXiaoliang Wang, Pooja Middha Kapoor, Paul L Auer, et al.
Breast Cancer Research : BCR|February 18, 2016
Genetic predisposition to ductal carcinoma in situ of the breastChristos Petridis, Mark N Brook, Vandna Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Scientific Reports|October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosisMaria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Pageof 36